EP 2083827 A1 20090805 - USE OF ESTRADIOL VALERATE OR 17 -ESTRADIOL IN COMBINATION WITH DIENOGEST FOR ORAL THERAPY FOR MAINTAINING AND/OR INCREASING THE FEMALE LIBIDO
Title (en)
USE OF ESTRADIOL VALERATE OR 17 -ESTRADIOL IN COMBINATION WITH DIENOGEST FOR ORAL THERAPY FOR MAINTAINING AND/OR INCREASING THE FEMALE LIBIDO
Title (de)
VERWENDUNG VON ESTRADIOLVALERAT ODER 17ß-ESTRADIOL IN KOMBINATION MIT DIENOGEST ZUR ORALEN THERAPIE FÜR DEN ERHALT UND/ODER STEIGERUNG DER WEIBLICHEN LIBIDO
Title (fr)
UTILISATION DE VALÉRATE D' STRADIOL OU DE 17 - STRADIOL EN COMBINAISON AVEC DU DIÉNOGEST POUR LA THÉRAPIE ORALE DE MAINTIEN ET/OU D'AUGMENTATION DE LA LIBIDO FÉMININE
Publication
Application
Priority
- EP 2007008866 W 20071012
- EP 06022091 A 20061020
- EP 07009373 A 20070510
- EP 07818937 A 20071012
Abstract (en)
[origin: WO2008046559A1] The invention relates to the use of estradiol valerate or estradiol in combination with 17a-cyanomethyl-17-ß-hydroxyestra-4,9-dien-3-one (dienogest) in a multiphase or single-phase combination preparation for oral therapy for maintaining and/or increasing the female libido, optionally also in unity with oral contraception. The total daily dose units of the multiphase combination and of the pharmaceutically acceptable placebo or of the single-phase combination and the active-ingredient-free and placebo-free daily dose units correspond to 28 days.
IPC 8 full level
A61K 31/565 (2006.01); A61K 31/57 (2006.01); A61P 15/00 (2006.01); A61P 15/12 (2006.01); A61P 15/18 (2006.01)
CPC (source: EP KR US)
A61K 31/565 (2013.01 - EP KR US); A61K 31/57 (2013.01 - EP KR US); A61P 15/00 (2017.12 - EP); A61P 15/12 (2017.12 - EP); A61P 15/18 (2017.12 - EP); A61P 43/00 (2017.12 - EP)
Citation (search report)
See references of WO 2008046559A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR
Designated extension state (EPC)
HR
DOCDB simple family (publication)
WO 2008046559 A1 20080424; AU 2007312626 A1 20080424; BR PI0717462 A2 20131224; CA 2666829 A1 20080424; CA 2666829 C 20120207; CO 6160297 A2 20100520; CR 10732 A 20090525; EA 016631 B1 20120629; EA 200900491 A1 20091030; EP 1930010 A1 20080611; EP 2083827 A1 20090805; GT 200900090 A 20111129; IL 198200 A0 20091224; IL 198200 A 20121031; JP 2010506867 A 20100304; KR 20090080989 A 20090727; MX 2009004179 A 20090430; NO 20091954 L 20090519; NZ 576336 A 20120330; SV 2009003231 A 20091109; US 2008125401 A1 20080529; US 8349820 B2 20130108
DOCDB simple family (application)
EP 2007008866 W 20071012; AU 2007312626 A 20071012; BR PI0717462 A 20071012; CA 2666829 A 20071012; CO 09039733 A 20090420; CR 10732 A 20090420; EA 200900491 A 20071012; EP 07009373 A 20070510; EP 07818937 A 20071012; GT 200900090 A 20090420; IL 19820009 A 20090419; JP 2009532710 A 20071012; KR 20097010244 A 20071012; MX 2009004179 A 20071012; NO 20091954 A 20090519; NZ 57633607 A 20071012; SV 2009003231 A 20090420; US 87359507 A 20071017